Nanopharmaceuticals Market is estimated to be 47.3 Billion by 2034 with a CAGR of 6.80% during the forecasted period.

Download Sample

Published Date: February 2024

The nanopharmaceuticals market accounted for US$ 26 billion in 2024 and is estimated to be 47.3 billion by 2034 and is anticipated to register a CAGR of 6.80%. The report. "Nanopharmaceuticals Market, By Drug Carrier (Liposomes, Polymer, Nanocrystals, Inorganic, Protein, and Others), By Application (Oncology, Neurology, Anti-inflammatory/Immunology, Anti-infective, Cardiovascular/Physiology, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”.

Key highlights:

On March 2020, Teva Pharmaceuticals USA, Inc., and Celltrion Healthcare, Co., Ltd. declared HERZUMA 1 (trastuzumab-pkrb) for Injection, a biosimilar to HERCEPTIN 1, is now available in the U.S. HERZUMA is indicated for the adjuvant treatment of HER2-overexpressing node-positive or node-negative (ER/PR negative or with one high-risk feature) breast cancer.
On December 2019, Johnson & Johnson declared the acquisition of TARIS Biomedical LLC (TARIS), a privately-owned biotechnology company focusing on development of a novel drug delivery technology for the treatment of bladder diseases including cancer. The company's lead clinical-stage product, TAR-200, uses the proprietary TARIS System, which features a silicone-based drug delivery device that permits for the continuous release of medication into the bladder.

Analyst View:

Growth in the prevalence of chronic diseases such as infectious diseases, cancer, and cardiovascular diseases, is one of the main driver propelling the global nanopharmaceuticals market. Prominent players are investing on large scale in the nanopharmaceuticals market in order to launch improved medicines in the target market. The advancements in the nanopharmaceuticals are probably to address therapeutics for critical diseases, which are yet to be explored. For example, In August 2017, Jazz Pharmaceuticals, a key player of nano-pharmaceuticals market received FDA approval for Vyxeos. Vyxeos is primarily used for the treatment of acute myeloid leukemia. Registering the developments and pace of research underway for nanopharmaceuticals, global nano-pharmaceuticals market is estimated to rise at a significant pace in the coming years.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Nanopharmaceuticals Market”, By Drug Carrier (Liposomes, Polymer, Nanocrystals, Inorganic, Protein, and Others), By Application (Oncology, Neurology, Anti-inflammatory/Immunology, Anti-infective, Cardiovascular/Physiology, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Key Market Insights from the report:

The nanopharmaceuticals market accounted for US$ 26 billion in 2024 and is estimated to be 47.3 billion by 2034 and is anticipated to register a CAGR of 6.80%.The market report has been segmented on the basis of drug carrier, application, distribution channel, and region.

By drug carrier, the global nanopharmaceuticals market is segmented into liposomes, polymer, nanocrystals, inorganic, protein, and others
By application, target market is classified into oncology, neurology, anti-inflammatory/immunology, anti-infective, cardiovascular/physiology, and others
By distribution channel, the target market is classified into hospital pharmacies, retail pharmacies, and online pharmacies.
By region, North America is expected to register highest share of the global nanomedicine market and maintain its position over the forecast period, owing to growing presence of patented nanomedicine products. Additionally, rapid acceptance of nanomedicine and the availability of advanced healthcare infrastructure and are some of the other major factors that are projected to improve the growth of the nanopharmaceuticals market in North America in the future.

Competitive Landscape:

The prominent player operating in the global nanopharmaceuticals market includes Teva Pharmaceuticals Industries Limited, AbbVie Inc., JOHNSON & JOHNSON, Novartis AG, Hoffmann-La Roche AG, Shire Plc., Pfizer Inc., Merck & Co., Sanofi S.A., AMAG Pharmaceuticals, and Amgen Inc.

The market provides detailed information regarding industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included into the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces Analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period

Key Topics Covered